With the COVID-19 pandemic firmly established in the United States and taking hold in Minnesota, there are several things that can and should be done now to prepare for events in the coming weeks and months and to reduce their impact on the physical, mental and financial health of the state and the nation.
As of 11 a.m. Central time on March 16, there were at least 3,823 confirmed cases and 67 deaths in the United States. In Minnesota, as of Monday afternoon, there were 54 active cases and fortunately no deaths.
Most early models suggest the COVID-19 pandemic will get much worse before it gets better. Early projections from the Centers for Disease Control and Prevention (CDC) regarding the potential toll of COVID-19 in terms of total number of infections, hospitalizations and deaths are striking in the worst-case scenarios where little is done at the population level to slow disease transmission. Between 160 million and 240 million people could be infected and between 200,000 and 1.7 million could die (a really bad year of seasonal flu kills approximately 60,000 and the 2009 H1N1 pandemic flu killed about 13,000).
The good news is that quick action and preparedness can dramatically slow the spread of COVID-19 and reduce the number of infections. Strong evidence already exists showing well-prepared countries that act quickly to control spread see far fewer cases of COVID-19 and correspondingly realize far fewer deaths. Singapore and Hong Kong are model examples of how comprehensive public health measures save lives. Even in China, where the pandemic began, comprehensive public health measures in all non-Hubei provinces produced a stark difference in the number of infections (67,790 in Hubei province vs. 13,186 in the rest of China). More important, because transmission was controlled in non-Hubei provinces, the early evidence is that COVID-19 mortality rates will be far lower outside of Hubei. As of Sunday, there were 3,193 COVID-19 deaths in China, and 3,075 of those were in Hubei province, which accounts for 4% of China's population — that is, 95% of deaths so far in China have occurred among 4% of the population, and this is almost entirely due to public health efforts to slow transmission outside of Hubei.
The concept of slowing transmission is frequently described as "flattening the curve," which refers to minimizing the upper limit of infections that develop and spreading them out over time, as nicely described in a recent article.
Despite clear evidence that COVID-19 is here to stay for the foreseeable future, and strong evidence that quick public health action centered around COVID-19 testing and social distancing can dramatically reduce the impact of COVID-19, skepticism remains among some members of our communities as to the seriousness of the threat. Some question the value of social distancing and worry that the toll on the economy is of greater concern than the toll on human health and loss of life. This opinion is often based on early data suggesting that about 80% of cases are mild and that children appear to be minimally affected.
While these data offer optimism, the numbers should not lead to complacency, for at least two key reasons. First, broad transmission will result in significant premature loss of life among people with pre-existing conditions (e.g., diabetes, cardiovascular disease and otherwise compromised immune systems) and the elderly, because infected individuals with mild symptoms will propagate transmission despite low risk to themselves. Second, the threat of COVID-19 is not just the infection itself but the indirect threat it poses even to vulnerable populations who never get infected. This is because of the potential for this pandemic to overwhelm the health care system. We now turn our focus to this threat, what is being done to prepare and how communities can aid in the effort.
Reducing the burden of COVID-19 on the health care system is of paramount importance. This plays out via many possible scenarios, but the most obvious is the threat of overwhelming hospitals, which not only will reduce our ability to contain COVID-19 but also will greatly impact the delivery of essential clinical care for non-COVID-19 conditions — particularly, chronic conditions including coronary heart disease, heart failure, stroke and diabetes.